SCHEMBL29408993

SCHEMBL29408993

CC(C)(C)OC(=O)NC12CCC(C(=O)NCc3ccc(C(F)(F)F)cn3)(CC1)CC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.42
HSD11B2 P80365 1/20 0.42
POLB P06746 2/20 0.38
GAA P10253 1/20 0.38
BACE1 P56817 1/20 0.38
TRPA1 O75762 1/20 0.36
GLS O94925 2/20 0.35
PDE7B Q9NP56 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
KDM1A O60341 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
SCN9A Q15858 1/20 0.34
CACNA1H O95180 1/20 0.34
CACNA1B Q00975 1/20 0.34
CACNA1C Q13936 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22614357 0.85 HSD11B1 (0.42) HSD11B1HSD11B2POLBGAABACE1
SCHEMBL29408862 0.81 KMT2A (0.43) HSD11B1HSD11B2POLBGAABACE1
SCHEMBL22614051 0.81 KMT2A (0.43) HSD11B1HSD11B2POLBGAABACE1
SCHEMBL29499461 0.77 KDM1A (0.43) HSD11B1POLBGAABACE1TRPA1
SCHEMBL22613728 0.76 ATF4 (0.45) HSD11B1HSD11B2BACE1CCNE1CDK2
SCHEMBL22613729 0.76 ATF4 (0.45) HSD11B1HSD11B2BACE1CCNE1CDK2
SCHEMBL29409184 0.76 ATF4 (0.45) HSD11B1HSD11B2BACE1CCNE1CDK2
SCHEMBL22613977 0.76 POLB (0.46) POLBGAABACE1TRPA1GLS
SCHEMBL29409182 0.76 POLB (0.46) POLBGAABACE1TRPA1GLS
SCHEMBL16256051 0.76 POLB (0.40) POLBGAABACE1GLSKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145594-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2025-05-08 US disclosed
EP-4237413-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2023-09-06 EP disclosed
WO-2022094244-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2022-05-05 WO disclosed
EP-3962906-A1 SUBSTITUTED CYCLOALKYLS AS MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2022-03-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145594-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 HSD11B1 63/4885HSD11B2 86/4885POLB 1432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.